Cas 1010701-89-9,N-[(1R)-1-((4R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-hydroxyethyl]carbamic acid benzyl ester

1010701-89-9

Post Buying Request

Basic information

Product Name: N-[(1R)-1-((4R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-hydroxyethyl]carbamic acid benzyl ester
Synonyms: N-[(1R)-1-((4R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-hydroxyethyl]carbamic acid benzyl ester
CAS NO:1010701-89-9
Molecular Formula:
Molecular Weight: 295.335
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-[(1R)-1-((4R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-hydroxyethyl]carbamic acid benzyl ester(CAS DataBase Reference)
NIST Chemistry Reference: N-[(1R)-1-((4R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-hydroxyethyl]carbamic acid benzyl ester(1010701-89-9)
EPA Substance Registry System: N-[(1R)-1-((4R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-hydroxyethyl]carbamic acid benzyl ester(1010701-89-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1010701-89-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1010701-89-9 Suppliers

Recommended suppliers

1010701-89-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1010701-89-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,0,7,0 and 1 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1010701-89:
(9*1)+(8*0)+(7*1)+(6*0)+(5*7)+(4*0)+(3*1)+(2*8)+(1*9)=79
79 % 10 = 9
So 1010701-89-9 is a valid CAS Registry Number.

1010701-89-9Upstream product

1010701-89-9Downstream Products

1010701-89-9Relevant academic research and scientific papers

ACYCLIC AMINE INHIBITORS OF NUCLEOSIDE PHOSPHORYLASES AND HYDROLASES

-

Page/Page column 77; 78, (2008/06/13)

The invention relates to compounds of the general formula (I) which are inhibitors of purine nucleoside phosphorylases (PNPs) and/or nucleoside hydrolases (NHs). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1010701-89-9